NRGN Human
|
|
|
6H,7H,8H,9H,11H-Pyrido[2,1-b]quinazolin-11-one
|
|
2446-62-0
|
[(1R,2E,8S,10R,11S)-6-(Acetyloxymethyl)-11-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] (E)-2- methylbut-2-enoate
|
|
83182-58-5
|
1-Methyl-4-nitro-1H-pyrazol-3-ol
|
|
1458593-78-6
|
Pyridine-3-yl-methanesulfonyl chloride hydrochloride
|
|
191105-35-8
|
C-Peptide 1 (rat)
|
|
41475-27-8
|
6-Fluoro-2H-chromene-3-carboxylic acid
|
|
452076-93-6
|
N-Ethyl-4-chloroaniline
|
|
13519-75-0
|
Solvent Blue 4
|
|
6786-83-0
|
4-Amino-5-chloro-2-methoxybenzamide
|
|
24190-74-7
|
4-Ethyl-1H-pyrrole-2-carboxylic acid
|
|
1354769-90-6
|
Complement C3 antibody
|
|
|
{4H,5H,6H,7H-Pyrazolo[1,5-a]pyrazin-3-yl}methanol
|
|
1221279-26-0
|
Sasanlimab
|
|
2206792-50-7
|
Isoglabrone
|
|
1115012-65-1
|
1,2-Distearoyl-d70-sn-glycero-3-phosphocholine-1,1,2,2-d4
|
|
326495-38-9
|
Methyl 5-bromo-2-nitrobenzoate
|
|
883554-93-6
|
2-Isopropyl-6-methylpyrimidin-4-amine
|
|
4595-70-4
|
1-(2-Ethoxyethyl)-piperazine
|
|
13484-38-3
|
5-(2-Fluorophenyl)-5-methylimidazolidine-2,4-dione
|
|
7248-25-1
|
7-Methyl-1H-indol-5-ol
|
|
53233-87-7
|
MLTK antibody
|
|
|
TACI antibody
|
|
|
2,3-Dihydro-1-benzofuran-5-sulfonyl azide
|
|
1152874-08-2
|
5-({[2-(Dimethylamino)ethyl](methyl)amino}methyl)pyridin-2-amine
|
|
1197332-20-9
|
tert-Butyl 6-chloro-1H,2H,3H-pyrrolo[2,3-b]pyridine-1-carboxylate
|
|
679392-22-4
|
Anti VIP (Human, Porcine) Serum
|
|
|
Rabbit anti Mouse Lambda Chain (biotin)
|
|
|
2-[(4-Formyl-1,3-dimethyl-1H-pyrazol-5-yl)sulfanyl]acetic acid
|
|
1221725-60-5
|
Methyl 5-amino-3-chloro-2-fluorobenzoate
|
|
1507502-79-5
|
1-[(4-Amino-3-fluorophenyl)methyl]pyrrolidin-3-ol dihydrochloride
|
|
1803582-76-4
|
RNF126 antibody
|
|
|
3-(Chloromethyl)-1-(4-fluorophenyl)-1H,4H,5H,6H-cyclopenta[C]pyrazole
|
|
1221726-10-8
|
3-Chloro-4-(2-methoxy-ethoxy)-phenylamine
|
|
879047-68-4
|
4-Amino-2-bromopyridine-3-carbonitrile
|
|
1806963-70-1
|
(2,2-Dimethylthiolan-3-yl)methanol
|
|
83413-95-0
|
YASESISGIPSR* – SIL Cetuximab signature peptide quantifier
|
|
|
N-(2-Aminoethyl)-N-[5-(trifluoromethyl)-pyridin-2-yl]amine
|
|
207557-34-4
|
Acamprosate calcium salt - Bio-X ?
|
|
77337-73-6
|
2-[(2,4-Dichlorobenzoyl)amino]acetic acid
|
|
7554-79-2
|
7,8,3'-Trihydroxyflavone
|
|
137502-84-2
|
5-Fluoro-2,3-dihydro-1-benzofuran-3-carboxylic acid
|
|
93670-19-0
|
Goat anti Human IgE (epsilon chain) (FITC)
|
|
|
3-Chloro-4-(piperidin-1-yl)phenol hydrobromide
|
|
1909312-54-4
|
Cholic acid monoclonal antibody
|
|
|
H-TSDLIVLGLPWK-OH
|
|
|
Measles Virus IgM Positive Human Plasma
|
|
|
H-AEVIWTSSDHQVLSGK-OH
|
|
|
3,10-Dioxa-7-azaspiro[5.6]dodecane
|
|
2260936-88-5
|
GD1b-Ganglioside ammonium
|
|
19553-76-5
|
Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside
|
|
99409-32-2
|
Globotriose-APE-HSA
|
|
|
Diethyl 2-(2,2,2-trifluoroacetyl)succinate
|
|
94633-25-7
|
Trifluoroacetaldehyde methyl hemiacetal
|
|
431-46-9
|
5-Bromo-2-(1H-imidazol-2-yl)pyridine
|
|
1211586-40-1
|
4-Bromo-2-sulfanylbenzoic acid
|
|
116209-30-4
|
Tripelennamine
|
|
91-81-6
|
5-Chloroquinazolin-2-amine
|
|
190273-70-2
|
2-Dechloroethylifosfamide
|
|
53459-55-5
|
Potassium 2-fluoro-2-(4-methyl-1,3-thiazol-2-yl)acetate
|
|
1461715-74-1
|
N-(2,4-Difluorophenyl)-2-indol-3-yl-2-oxoethanamide
|
|
946387-17-3
|
H-EEAPSLRPAPPPISGGGYR-OH
|
|
|
D-Gln19-Tirzepatide
|
|
|
N6-Benzoyl-5'-O-DMT-adenosine 3'-CE phosphoramidite
|
|
|
tert-Butyl 5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
|
|
216064-48-1
|
Locustachykinin II
|
|
|
Methyl 1-boc-3-hydroxyazetidine-3-carboxylate
|
|
1884303-05-2
|
1-[(4-Hydroxyphenyl)methyl]cyclopropane-1-carboxylic acid
|
|
1512778-52-7
|
DLK2 antibody
|
|
|
tert-Butyl (2E)-3-[4-(benzyloxy)phenyl]prop-2-enoate
|
|
691905-29-0
|
3-[2-(Difluoromethoxy)phenyl]-1,2-oxazol-5-amine
|
|
1021245-69-1
|
N,N'-Dibenzoyl-L-cystine
|
|
25129-20-8
|
Benzeneacetic acid, 3,5-difluoro-hydroxy-, (S)-
|
|
209982-91-2
|
Amyloid beta-Protein (25-35) amide trifluoroacetate salt
|
|
147490-49-1
|
NHS-Biotin
|
|
35013-72-0
|
6-(Bromomethyl)-2,2-dimethyloxane
|
|
1871726-65-6
|
3-(Difluoromethyl)-4-methyl-4H-1,2,4-triazole
|
|
1461706-95-5
|
5-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole hyrochloride
|
|
2377608-65-4
|
2-(Piperidin-4-yl)benzonitrile
|
|
304462-63-3
|
2,5-Dichloro-1,4-benzoquinone
|
|
615-93-0
|
Ehrlichia Canis gp36 Antigen, Recombinant
|
|
|
Pulcherriminic acid
|
|
957-86-8
|
2-Debenzoyl paclitaxel 2-pentanoate
|
|
213767-22-7
|
5-Methyl-2-oxo-1,3-oxazolidine-4-carboxylic acid
|
|
1195-19-3
|
5-Methoxy-1,3-dimethyl-1H-pyrazole-4-carbonitrile
|
|
1343203-74-6
|
Erk1/2 inhibitor 1
|
|
2095719-90-5
|
APP antibody (HRP)
|
|
|
alpha Actinin 1 Blocking Peptide
|
|
|
CHAC1 Blocking Peptide
|
|
|
H-ISQAVHAAHAEINEA-OH
|
|
|
Edivoxetine hydrochloride
|
|
1194374-05-4
|
Methyl 2-(2-oxo-1,2,3,4-tetrahydroquinolin-1-yl)acetate
|
|
600167-15-5
|
4-Chloro-2-[(2,2,2-trifluoroethyl)amino]benzoic acid
|
|
1341457-94-0
|
5-(1-Phenyl-1H-pyrazol-4-yl)-1,2-oxazole-4-carboxylic acid
|
|
1500627-24-6
|
NMDAR2A antibody
|
|
|
2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)acetic acid hydrochloride
|
|
1170172-16-3
|
[6-(Aminomethyl)piperidin-2-yl]methanol
|
|
1461714-67-9
|
tert-Butyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate
|
|
1360617-83-9
|
2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carbonitrile
|
|
1211515-10-4
|
7-Hydroxy-4-chromone
|
|
59887-89-7
|